The Use of Ranibizumab in Age Related Macular Degeneration Patients With Low Visual Acuity

被引：0
|
作者：
Niskopoulou, M. [1 ]
Kotsolis, A. [1 ]
Massaoutis, P. [1 ]
Mpaltatzis, S. [1 ]
Ladas, I. D. [1 ]
机构：
[1] AUniv Clin, Med Retina Dept, Ophthalmol, Athens, Greece
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
age-related macular degeneration; retina;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
914
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
    Wachtlin, Joachim
    Spital, Georg
    Schmitz-Valckenberg, Steffen
    Liakopoulos, Sandra
    Voegeler, Jessica
    Mueller, Bettina
    Ziemssen, Focke
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [42] Ranibizumab for Age-related Macular Degeneration
    Seider, Michael I.
    Stewart, Jay M.
    OPHTHALMOLOGY, 2011, 118 (08) : 1693 - 1694
  • [43] Longitudinal Changes in Microperimetry and Low Luminance Visual Acuity in Age-Related Macular Degeneration
    Wu, Zhichao
    Ayton, Lauren N.
    Luu, Chi D.
    Guymer, Robyn H.
    JAMA OPHTHALMOLOGY, 2015, 133 (04) : 442 - 448
  • [44] Ranibizumab for age-related macular degeneration
    Dhoot, Dilsher S.
    Kaiser, Peter K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (03) : 371 - 381
  • [45] FUSION regimen: ranibizumab in treatment-naive patients with exudative age-related macular degeneration and relatively good baseline visual acuity
    Mones, Jordi
    Biarnes, Marc
    Trindade, Fabio
    Casaroli-Marano, Ricardo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (12) : 1737 - 1744
  • [46] Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
    Ross, A. H.
    Donachie, P. H. J.
    Sallam, A.
    Stratton, I. M.
    Mohamed, Q.
    Scanlon, P. H.
    Kirkpatrick, J. N.
    Johnston, R. L.
    EYE, 2013, 27 (01) : 56 - 64
  • [47] CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The LUMIERE Study
    Cohen, Salomon Y.
    Mimoun, Gerard
    Oubraham, Hassiba
    Zourdani, Alain
    Malbrel, Christian
    Quere, Stephane
    Schneider, Veronique
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (03): : 474 - 481
  • [48] Current Smoking Is Associated with a Poor Visual Acuity Improvement after Intravitreal Ranibizumab Therapy in Patients with Exudative Age-Related Macular Degeneration
    Lee, Sangmoon
    Song, Su Jeong
    Yu, Hyeong Gon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (05) : 769 - 774
  • [49] CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The TWIN Study
    Souied, Eric H.
    Oubraham, Hassiba
    Mimoun, Gerard
    Cohen, Salomon Y.
    Quere, Stephane
    Derveloy, Audrey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (09): : 1743 - 1749
  • [50] Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
    A H Ross
    P H J Donachie
    A Sallam
    I M Stratton
    Q Mohamed
    P H Scanlon
    J N Kirkpatrick
    R L Johnston
    Eye, 2013, 27 : 56 - 64
12345